Research Calls I
-
Upgrades:
- Brighthouse Financial (BHF) upgraded to Equal Weight from Underweight at Wells Fargo; tgt raised to $59
- Capital One (COF) upgraded to Buy from Neutral at BofA Securities; tgt raised to $235
- Glaukos (GKOS) upgraded to Outperform from Neutral at Mizuho; tgt raised to $200
- Illinois Tool (ITW) upgraded to Hold from Sell at Deutsche Bank; tgt $257
- NetApp (NTAP) upgraded to Neutral from Underperform at BofA Securities; tgt raised to $128
- STMicroelectronics (STM) upgraded to Buy from Hold at Jefferies
- Travelers (TRV) upgraded to Outperform from Mkt Perform at Keefe Bruyette; tgt raised to $286
-
Downgrades:
- Baidu (BIDU) downgraded to Neutral from Buy at Nomura
- Bio-Techne (TECH) downgraded to Neutral from Outperform at Robert W. Baird; tgt lowered to $68
- Essential Properties Realty Trust (EPRT) downgraded to Neutral from Buy at B. Riley Securities; tgt raised to $33.50
- ICICI Bank (IBN) downgraded to Hold from Buy at Erste Group
- Qiagen (QGEN) downgraded to Neutral from Outperform at Robert W. Baird; tgt lowered to $42
- Supernus Pharma (SUPN) downgraded to Neutral from Overweight at Cantor Fitzgerald; tgt lowered to $36
- Tactile Systems (TCMD) downgraded to Neutral from Buy at B. Riley Securities; tgt lowered to $18
- TRI Pointe Homes (TPH) downgraded to Sector Perform from Outperform at RBC Capital Mkts; tgt lowered to $37
- Valmont (VMI) downgraded to Neutral from Buy at DA Davidson; tgt $380
- Workday (WDAY) downgraded to Equal-Weight from Overweight at Morgan Stanley; tgt lowered to $275
-
Others:
- Candel Therapeutics (CADL) initiated with a Buy at Canaccord Genuity; tgt $20
- Coincheck Group N.V. (CNCK) initiated with an Overweight at Cantor Fitzgerald; tgt $10
- Compass Therapeutics (CMPX) initiated with an Overweight at Piper Sandler; tgt $12
- Electronic Arts (EA) initiated with a Neutral at DA Davidson; tgt $140
- Lightspeed (LSPD) initiated with a Buy at BofA Securities; tgt $20
- Stanley Black & Decker (SWK) initiated with a Buy at Jefferies; tgt $103
- Take-Two (TTWO) initiated with a Buy at DA Davidson; tgt $250
- UroGen Pharma (URGN) resumed with a Buy at Ladenburg Thalmann; tgt $31